LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, it contributes to the advancement of life sciences in Vienna. LISAvienna supports innovative biotech, pharmaceutical and medical technology companies in Vienna that develop and market new products, services and processes. The platform links these companies with development partners and key customers. As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.
The highest-ranking body of LISAvienna is the working community council (ARGE Rat), in which both LISAvienna partners are represented. The ARGE Rat makes decisions regarding the further development of the working community. Marlis Baurecht is a member of this committee as a representative of austria wirtschaftsservice, while the Vienna Business Agency is represented by Eva Czernohorszky. The Managing Directors Johannes Sarx (aws) and Peter Halwachs (Vienna Business Agency) manage the platform. The core team of LISAvienna includes Jürgen Fuchs (Technology Expert Biotech & Pharma), Martin Mayer (Technology Expert Medtech), Brigitte Tempelmaier (Project Manager Marketing & PR) and Andrea Jan Coleselli (Administration, Controlling and Events).
LISAvienna’s network includes a growing number of innovative companies and research institutions from Vienna, especially those focusing on biotech, pharmaceuticals, the bioeconomy, medical devices and digital health solutions. Enter the network by arranging an individual consulting meeting with the LISAvienna team and by attending our events – no formal membership is required.
Of course, we also collaborate with business associations and academic societies in the life sciences. Because of its special owner structure, LISAvienna is also closely connected with funding bodies and investors.